Is angiotensinogen gene polymorphism associated with hypertension in pregnancy?

Hypertension in Pregnancy

Volumn 18, Issue 3, 1999, Pages 261-271

  Suzuki, Yuka ^a   Tanemura, Mitsuyo ^a   Suzuki, Yoshikatsu ^a   Murakami, Isamu ^a   Suzumori, Kaoru ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensinogen M235T variant; Gestational hypertension; Preeclampsia

Indexed keywords

ANGIOTENSINOGEN;

ADULT; ARTICLE; BODY MASS; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; PARITY; PATHOGENESIS; PREECLAMPSIA; RISK ASSESSMENT;

EID: 0032882211     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641959909016199     Document Type: Article

References (18)

1. Adams EM, Finlayson A. Familial aspects of pre-eclampsia and hypertension in pregnancy. Lancet 1961;ii:1375-8.
2. Chesley LC, Annitto JE, Cosgrove RA. The familial factor in toxemia of pregnancy. Obstet Gynecol 1968;32:303-11.
3. Cooper DW, Liston WA. Genetic control of severe pre-eclampsia. J Med Genet 1979; 16:409-16.
4. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986;93:898-908.
5. Arngrimsson R, Bjornsson S, Geirsson RJ, Bjornsson H, Walker JJ, Snaedel G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990;97:762-9.
6. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71: 169-80.
7. Hata A. Role of angiotensinogen in the genetics of essential hypertension. Life Sci 1995;57:2385-95.
8. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J. M235 → T polymorphism of the angiotensinogen gene predicts hypertension in the elderly. J Hypertens 1996;14:1061-5.
9. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994;330:1629-33.
10. Morise T, Takeuchi Y, Takeda R. Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med 1995; 237:175-80.
11. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with pre-eclampsia. Nat Genet 1993;4:59-61.
12. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-7.
13. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 1990;163:1689-1712.
14. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997; 99:1786-97.
15. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, et al. Haplotypès of angiotensinogen in essential hypertension. Am J Hum Genet 1997;60:1448-60.
16. Sato N, Katsuya T, Rakugi H, Takami S, Nakata Y, Miki T, et al. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 1997;30:321-5.
17. Ishigami T, Umemura S, Tamura K, Hibi K, Nyui N, Kihara M, et al. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension 1997;30:1325-30.
18. Nishida H, Sakamoto S, Sakanoue M. New fetal growth curves for Japanese. Acta Paediat Scand 1985;319(suppl):62-7.